Elion Therapeutics

Elion Therapeutics is a biotech company in New York, United States, founded in 2017. It has raised $81.0M across 1 round, most recently an $81.0M Series B in June 2024.

Transforming the treatment of invasive fungal infections.

Headquarters
New York
Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$81.0M
Last Round
$81.0M Series BJun 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

Elion Therapeutics is a biotechnology company focused on transforming the treatment of invasive fungal infections. The company's seasoned leadership team represents more than 200 years of collective expertise in antifungal drug development, spanning large pharma, academia, and clinical medicine. Elion is built on the belief that mechanistic insights enable the targeted optimization of natural products, allowing the company to develop novel antifungal agents that address critical unmet needs in both efficacy and safety. The company's pipeline targets life-threatening invasive fungal infections, for which current treatment options are limited by toxicity, drug resistance, and narrow-spectrum coverage. Elion closed an $81 million Series B financing round in June 2024 and has continued advancing its antifungal pipeline.

Summary

It lists 11–50 employees. It has raised $81.0M in total across 1 round, most recently a $81.0M Series B round in Jun 2024. Investors include Deerfield Management, AMR Action Fund and Illinois Ventures.

Funding History

Data from Indexed.vcUpdated
Series BSeries BJun 2024
$81.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Elion Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/elion-therapeutics"><img src="https://indexed.vc/api/badge/company/elion-therapeutics" alt="Elion Therapeutics on Indexed.vc" width="260" height="76" /></a>